Avalo Therapeutics, Inc.
AVTX
$19.94
-$0.31-1.53%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 98.34M | 111.62M | 113.26M | 125.05M | 134.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.91M | 2.14M | 1.90M | 1.83M | 4.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.00K | 90.00K | 20.00K | 62.00K | 19.00K |
| Total Current Assets | 105.29M | 113.85M | 115.19M | 126.94M | 138.89M |
|
|
|||||
| Total Current Assets | 105.29M | 113.85M | 115.19M | 126.94M | 138.89M |
| Net Property, Plant & Equipment | 460.00K | 542.00K | 686.00K | 949.00K | 1.21M |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 210.00K | 210.00K | 210.00K | 131.00K | 131.00K |
| Total Assets | 116.46M | 125.10M | 126.58M | 138.52M | 150.73M |
|
|
|||||
| Total Accounts Payable | 137.00K | 474.00K | 2.37M | 681.00K | 283.00K |
| Total Accrued Expenses | 12.41M | 6.77M | 5.68M | 3.69M | 5.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 392.00K | 438.00K | 482.00K | 526.00K | 568.00K |
| Total Finance Division Other Current Liabilities | -- | 291.00K | 729.00K | 719.00K | 894.00K |
| Total Other Current Liabilities | -- | 291.00K | 729.00K | 719.00K | 894.00K |
| Total Current Liabilities | 12.94M | 7.97M | 9.26M | 5.62M | 6.96M |
|
|
|||||
| Total Current Liabilities | 12.94M | 7.97M | 9.26M | 5.62M | 6.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 35.00K | 117.00K | 197.00K | 275.00K | 350.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.43M | 25.46M | 12.55M | 10.02M | 10.39M |
| Total Liabilities | 33.41M | 33.55M | 22.01M | 15.91M | 17.70M |
|
|
|||||
| Common Stock & APIC | 531.50M | 526.31M | 508.79M | 506.03M | 503.30M |
| Retained Earnings | -448.52M | -434.80M | -404.18M | -383.41M | -370.26M |
| Treasury Stock & Other | 68.00K | 41.00K | -34.00K | -- | -- |
| Total Common Equity | 83.05M | 91.55M | 104.57M | 122.62M | 133.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 83.05M | 91.55M | 104.57M | 122.62M | 133.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 83.05M | 91.55M | 104.57M | 122.62M | 133.03M |
|
|
|||||